Glaucoma: Clinical Trials

19 trials for Glaucoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

19 terminated. 19 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 419Terminated 19

Follow Glaucoma: new trials by email Literature Review of Glaucoma trials Research Report on Glaucoma

Trials (filtered) newest first · largest first

All 19 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Clinical Trial Comparing the OMNI Surgical System to Standard Medical Treatment in Patients With Primary Open Angle Glaucoma
OMNI Surgical System, Latanoprost plus adjunctive glaucoma medication - Primary Open Angle Glaucoma
Phase 4TerminatedSight Sciences, Inc.22024-08-212025-01-29
How Much Does Reduced Dosing of Latanoprost and Dorzolamide-timolol Affect Pressure?
dorzolamide/timolol - Glaucoma, Open-Angle, Glaucoma; Drugs
Phase 4TerminatedCT Glaucoma Associates362024-04-222024-08-23
Comparative Study of the Efficacy of Either Krytantek Ofteno PF® or Eliptic Ofteno PF® Plus Gaap Ofteno PF® for POAG or Ocular Hypertension.
Dorzolamide-timolol-brimonidine and latanoprost, Dorzolamide-timolol and latanoprost - Glaucoma, Open-Angle, Ocular Hypertension
Phase 4TerminatedLaboratorios Sophia S.A de C.V.282021-10-192026-05-07
Prospective Study on DEXTENZA® Safety And Efficacy Following Concomitant MIGS and Cataract Surgery
Dexamethasone Ophthalmic Insert, Prednisolone Acetate 1% Oph Susp - Glaucoma, Cataract
Phase 4TerminatedThe New York Eye Surgery Center252020-01-132024-01-31
Comparing Preoperative Injection of Mitomycin-C vs. Intraoperative Injection of Mitomycin-C vs. Topical Application of Mitomycin-C (Conventional Use) in Trabeculectomy
Mitomycin C - Glaucoma Open-Angle Primary, Glaucoma
Phase 4TerminatedUniversity of California, Los Angeles192019-03-302024-01-05
Safety and Efficacy of SIMBRINZA® BID as an Adjunctive to DUOTRAV®
Brinzolamide 1%/brimonidine tartrate 0.2% ophthalmic suspension, Brinzolamide/brimonidine vehicle, Travoprost 0.004%/timolol 0.5% solution - Open-angle Glaucoma, Ocular Hypertension
Phase 4TerminatedAlcon Research1732016-06-242019-05-29
Efficacy of the Brand-name Latanoprost and One of Its Generic Version in Primary Open Angle Glaucoma and Ocular Hypertension
Generic latanoprost, Brand-name latanoprost - Primary Open Angle Glaucoma, Ocular Hypertension
Phase 4TerminatedCHU de Quebec-Universite Laval602014-01-012017-07-25
TF (SENSIMED Triggerfish) in Intraocular Anti-VEGF (Vascular Endothelial Growth Factor) Injection
Intraocular anti-VEGF injection, SENSIMED Triggerfish - Neovascular Age Related Macular Degeneration (AMD), Open Angle Glaucoma
Phase 4TerminatedSensimed AG42013-10-012015-11-17
Evaluating the Efficacy of Fenestrations in Tube Shunt Implants During the Early Postoperative Period
Needle fenestration, Suture wick - Glaucoma
Phase 4TerminatedThe University of Texas Health Science Center, Houston182013-01-012018-02-05
Efficacy of Changing to DuoTrav® (Travoprost 0.004%/Timolol 0.5% BAK-Free Fixed Combination) From Prior Therapy
Travoprost/Timolol Maleate BAK-Free Fixed Combination - Glaucoma
Phase 4TerminatedAlcon Research372012-06-012014-12-03
Assessing the Efficacy and Tolerability of AZARGA® (Brinzolamide 1%/Timolol 0.5% Fixed Combination) as Replacement Therapy in Patients on COMBIGAN® (Brimonidine 0.2%/Timolol 0.5% Fixed Combination) Therapy in Brazil
Brinzolamide/timolol maleate fixed combination - Glaucoma
Phase 4TerminatedAlcon Research92012-03-012013-10-21
Effects of Anti-Glaucoma Medications on the Ocular Surface
Travoprost, Latanoprost - Glaucoma
Phase 4TerminatedMassachusetts Eye and Ear Infirmary142011-02-012017-03-16
Use of an Ocular Telemetry Sensor in Tafluprost Treated Patients
SENSIMED Triggerfish - Glaucoma
Phase 4TerminatedSensimed AG152010-09-012012-08-28
Study of Brimonidine and Timolol Ophthalmic Solution With Latanoprost Compared With Latanoprost in Glaucoma Patients
brimonidine 0.2%/timolol 0.5% fixed combination ophthalmic solution, latanoprost - Glaucoma, Angle-Closure
Phase 4TerminatedAllergan172009-11-012013-02-06
Reproducibility of Retinal Nerve Fiber Layer Thickness Measurements Using the Eye Tracker and Retest Function of Spectralis® SD-OCT in Glaucomatous Eyes and Healthy Controls
Spectralis® SD-OCT, Heidelberg Engineering GmbH, H - Glaucoma
Phase 4TerminatedUniversity of Zurich2009-01-012010-10-26
A Clinical Study Comparing the Inflammatory Response of the Ex-Press Mini Shunt to Trabeculectomy
Trabeculectomy with mitomycin c, Ex-Press mini shunt with mitomycin c - Glaucoma
Phase 4TerminatedIndiana University402007-11-012010-09-17
Study of Travatan and Cosopt in Primary Open-Angle Glaucoma or Ocular Hypertension
Travatan, Cosopt, Placebo (Timolol Vehicle) - Open-angle Glaucoma, Ocular Hypertension
Phase 4TerminatedAlcon Research462007-03-012012-04-11
Phase 4 Study Comparing IOP Lowering in OAG or OH in Caucasian or Japanese Subjects C-02-32
IOP Lowering Medications - Open-angle Glaucoma, Ocular Hypertension
Phase 4TerminatedAlcon Research842002-08-012012-08-17
INFLUENCE OF TOPICAL INDOMETHACIN ON HYPOTHENSIVE EFFECT OF BRIMONIDINE
brimonidine - Glaucoma
Phase 4TerminatedFederal University of São Paulo2006-10-26

Narrower conditions

Glaucoma, Open-Angle (11)  ·  Ocular Hypertension (7)  ·  Cataract (1)  ·  Dry Eye Syndromes (1)  ·  Glaucoma, Angle-Closure (1)  ·  Hypertension (1)

Broader conditions

Eye Diseases (19)  ·  Ocular Hypertension (12)  ·  Cardiovascular Diseases (1)  ·  Lacrimal Apparatus Diseases (1)  ·  Lens Diseases (1)  ·  Vascular Diseases (1)

Interventions

Latanoprost (6)  ·  Timolol (4)  ·  Travoprost (4)  ·  Brimonidine Tartrate (3)  ·  dorzolamide-timolol combination (3)  ·  Duotrav (2)  ·  Mitomycin (2)  ·  brinzolamide (2)  ·  Azarga (1)  ·  Brimonidine Tartrate, Timolol Maleate Drug Combination (1)  ·  Calcium Dobesilate (1)  ·  Methylprednisolone (1)  ·  Proton Therapy (1)  ·  Solutions (1)  ·  Trabeculectomy (1)

Sponsors

Alcon Research (5)  ·  Sensimed AG (2)  ·  Allergan (1)  ·  CHU de Quebec-Universite Laval (1)  ·  CT Glaucoma Associates (1)  ·  Federal University of São Paulo (1)  ·  Indiana University (1)  ·  Laboratorios Sophia S.A de C.V. (1)  ·  Massachusetts Eye and Ear Infirmary (1)  ·  Sight Sciences, Inc. (1)  ·  The New York Eye Surgery Center (1)  ·  The University of Texas Health Science Center, Houston (1)  ·  University of California, Los Angeles (1)  ·  University of Zurich (1)

Countries

United States (8)  ·  Brazil (2)  ·  Switzerland (2)  ·  Canada (1)  ·  Mexico (1)  ·  Portugal (1)  ·  Spain (1)  ·  Thailand (1)

Top investigators

Abayomi Ogundele, PharmD (1)  ·  Aline K Sousa, MD (1)  ·  Anna Grau (1)  ·  Doug Hubatsch, M.Sc. (1)  ·  Lauren S. Blieden, MD (1)  ·  Louis B Cantor, MD (1)  ·  Nathan M Radcliffe, MD (1)  ·  Pedram Hamrah, MD (1)  ·  Peter E Libre, MD (1)  ·  Roberto Gallego Pinazo (1)

Results publications

PMID 21330656, PMID 40873654

NIH funding

2016 (1)